CD274 and neoplasm: The in vitro and in vivo preclinical models used to test PD-(L)1 PET tracers have grown in complexity, from early studies using cell-line–based systems and mouse models (14, 16, 19, 77), including xenografts and other tumor models, to more recent studies using healthy non-human primates (11, 12) (Supplementary Table 1).